ACE; angiotensin converting enzyme; AEC; alveolar epithelial cells; AMs; alveolar macrophages; Andro; Andrographolide; ANG; angiotensin; ALI; acute lung injury; ARDS; acute respiratory distress syndrome; BA; boswellic acids; BAI; Baicalein; BALF; bronchoalveolar lavage fluid; BECs; bronchial epithelial cells; BLM; bleomycin; CAT; catalase; CCl4; carbon tetrachloride; COL1A1; procollagen type 1 a1; Col-I; collagen types I; COX; cyclooxygenase; CP; cyclophosphamide; CTGF; connective tissue growth factor; DBTG; total glucosides of Danggui-Buxue-Tang; DSQRL; Decoction for Strengthening Qi and Replenishing Lung; ECM; extracellular matrix; EGCG; epigallocatechin-3-gallate; EMT; epithelial-mesenchymal transition; EndoMT; endothelial-mesenchymal transition; EOCR; essential oil of Citrus reticulata; ESA; eclipta saponin A; ET; endothelin; FB; fibroblasts; FEV1; forced expiratory volume in one second; FGF; fibroblast growth factor; FN; fibronectin; FVC; forced vital capacity; GA; gallic acid; GBA; gambogic acid; GC-MS; gas chromatograph-mass spectrometer; GCA; glycyrrhizic acid; GPx; glutathione peroxidases; GR; glutathione reductase; GSH; glutathione; HC; Houttuynia cordata; HELFs; human embryonic lung fibroblast; HLF; human lung fibroblasts; HMGB1; high-mobility group box 1; HO-1; heme oxygenase-1; HPMECs; human pulmonary microvascular endothelial cells; HSM; Hirsutella sinensis mycelium; HSYA; hydroxy safflor yellow A; Hyp; hydroxyproline; IFN; interferon; IL; interleukin; iNOS; inducible nitric oxide synthase; IR; irradiation; Keap; Kelch like ECH-associated protein; LC3A/B; light chains 3A/B; LDH; lactate dehydrogenase; LOX; lipooxygenase; LPA1; lysophosphatidic acid receptor 1; LPO; lipid peroxide; LPS; lipopolysaccharide; MAPK; mitogen-activated protein kinases; MCP-1; monocyte chemoattractant protein-1; MDA; malondialdehyde; MFb; myofibroblasts; miR; miRNA; mKG; Modified Kushen Gancao Formula; MMP; matrix metalloproteinase; MPO; myeloperoxidase; NF-κB; nuclear factor kappa B; NLRP; NOD-like receptor; NOX; NADPH oxidase; NQO1; NAD(P)H:quinone oxidoreductase 1; Nrf2; nuclear factor erythroid 2-related factor; NS;
机译:肺纤维化治疗中药中药:进步与未来前景
机译:特发性肺纤维化中药外部治疗:文献分析
机译:中药对脑缺血-再灌注损伤的临床
机译:21世纪中医的当前趋势与未来前景
机译:特发性肺纤维化:发病机制,进展,治疗和未来前景
机译:中药对脑缺血-再灌注损伤的临床前体内模型的抗炎作用:神经保护药物发现和治疗的前景。
机译:特发性肺纤维化中药外部治疗:文献分析